Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Afinitor 10 mg Tablet EU/1/09/538/004

Everolimus

Novartis Europharm Limited

—

Afinitor 2.5 mg Tablet EU/1/09/538/009-010

Rad n bht

Novartis Europharm Limited

—

Afinitor 5 mg Tablet EU/1/09/538/001

Everolimus

Novartis Europharm Limited

—

Aimovig 140 mg Solution for injection EU/1/18/1293/004-006

ERENUMAB

Novartis Pharma GmbH

—

Aimovig 70 mg Solution for injection EU/1/18/1293/001-003

ERENUMAB

Novartis Europharm Limited

—

Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules EU/1/20/1439/005-008

Indacaterol acetate, Mometasone furoate

Novartis Europharm Limited

—

Atectura Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules EU/1/20/1439/009-012

Indacaterol acetate, Mometasone furoate

Novartis Europharm Limited

—

Atectura Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules EU/1/20/1439/001-004

Indacaterol acetate, Mometasone furoate

Novartis Europharm Limited

—

Azarga 10 mg/ml + 5 mg/ml eye drops, suspension EU/1/08/482/1-2

Timolol Maleate, Brinzolamide

Novartis Europharm Limited

—

Azopt 10 mg/ml eye drops, suspension EU/1/00/129/001

Brinzolamide

Novartis Europharm Limited

—

Azopt 10 mg/ml eye drops, suspension EU/1/00/129/002

Brinzolamide

Novartis Europharm Limited

—

Bemrist Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsules EU/1/20/1441/005-008

Indacaterol acetate, Indacaterol, Mometasone furoate

Novartis Europharm Limited

—

Bemrist Breezhaler 125 micrograms/260 micrograms inhalation powder, hard capsules EU/1/20/1441/009-012

Indacaterol acetate, Indacaterol, Mometasone furoate

Novartis Europharm Limited

—

Bemrist Breezhaler 125 micrograms/62.5 micrograms inhalation powder, hard capsules EU/1/20/1441/001-004

Indacaterol acetate, Indacaterol, Mometasone furoate

Novartis Europharm Limited

—

Beovu 120 mg/ml solution for injection in pre-filled syringe EU/1/19/1417/001-002

Brolucizumab

Novartis Europharm Limited

—

Cataflam 50mg Coated Tablets PA0896/004/001

Diclofenac potassium

Novartis Ireland Limited

Marketed

Certican 0.25mg Tablets PA0896/005/001

Everolimus

Novartis Ireland Limited

Not marketed

Certican 0.75mg Tablets PA0896/005/003

Everolimus

Novartis Ireland Limited

Not marketed

Ciloxan 3 mg/ml ear drops, solution PA0896/006/001

Ciprofloxacin

Novartis Ireland Limited

Marketed

Co-Diovan 160 mg/12.5 mg film-coated tablets PA0896/007/002

Valsartan, Hydrochlorothiazide

Novartis Ireland Limited

Marketed

Co-Diovan 160 mg/25 mg film-coated tablets PA0896/007/003

Valsartan, Hydrochlorothiazide

Novartis Ireland Limited

Marketed

Co-Diovan 320 mg/12.5 mg film-coated tablets PA0896/007/004

Valsartan, Hydrochlorothiazide

Novartis Ireland Limited

Marketed

Co-Diovan 320 mg/25 mg film-coated tablets PA0896/007/005

Valsartan, Hydrochlorothiazide

Novartis Ireland Limited

Marketed

Co-Diovan 80 mg/12.5 mg film-coated tablets PA0896/007/001

Valsartan, Hydrochlorothiazide

Novartis Ireland Limited

Marketed

Copalia 10 mg/160 mg film-coated tablets EU/1/06/372/017-024

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Copalia 5 mg/160 mg film-coated tablets EU/1/06/372/009-016

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Copalia 5 mg/80 mg film-coated tablets EU/1/06/372/001-008

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Copalia HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/575/13-24

Hydrochlorothiazide, Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Copalia HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/575/37-48

Hydrochlorothiazide, Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Copalia HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/575/49-60

Valsartan, Hydrochlorothiazide, Amlodipine besilate

Novartis Europharm Limited

—

Copalia HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/575/1-12

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Copalia HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/575/25-36

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Cosentyx 150 mg Powder for solution for injection EU/1/14/980/001

Secukinumab

Novartis Europharm Limited

—

Cosentyx 150 mg Solution for injection pre-filled pen EU/1/14/980/004-005

Secukinumab

Novartis Europharm Limited

—

Cosentyx 150 mg Solution for injection pre-filled syringe EU/1/14/980/002-003

Secukinumab

Novartis Europharm Limited

—

Cosentyx 300 mg Solution for injection in pre-filled pen EU/1/14/980/10-011

Secukinumab

Novartis Europharm Limited

—

Cosentyx 300 mg Solution for injection in pre-filled syringe EU/1/14/980/008-009

Secukinumab

Novartis Europharm Limited

—

Cosentyx 75 mg Solution for injection pre-filled syringe EU/1/14/980/012-013

Secukinumab

Novartis Europharm Limited

—

Dafiro 10 mg/160 mg film-coated tablets EU/1/06/371/017-024

Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Dafiro 5 mg/160 mg film-coated tablets EU/1/06/371/009-016

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Dafiro 5 mg/80 mg film-coated tablets EU/1/06/371/001-008

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/574/13-24

Hydrochlorothiazide, Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/574/37-48

Hydrochlorothiazide, Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Dafiro HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/574/49-60

Valsartan, Hydrochlorothiazide, Amlodipine besilate

Novartis Europharm Limited

—

Dafiro HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/574/1-12

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/574/25-36

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Diovan 160 mg film-coated tablets PA0896/009/002

Valsartan

Novartis Ireland Limited

Marketed

Diovan 320 mg film-coated tablets PA0896/009/004

Valsartan

Novartis Ireland Limited

Marketed

Diovan 3mg/ml oral solution PA0896/009/005

Valsartan

Novartis Ireland Limited

Marketed

Diovan 40 mg film-coated tablets PA0896/009/003

Valsartan

Novartis Ireland Limited

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 28 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.